Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B Vaccination Schemas in HIV-Positive Youth
NCT00106964Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2004
- Primary completion
- Jan 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 3
01
Overview
A Phase 4 trial of Hepatitis B vaccine, hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by University of North Carolina at Chapel Hill. Started Jan 2004; status: completed.
02
Drugs
Hepatitis B vaccinehepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00106964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106964.